A detailed history of Hgc Investment Management Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Hgc Investment Management Inc. holds 69,659 shares of CTLT stock, worth $4.42 Million. This represents 10.82% of its overall portfolio holdings.

Number of Shares
69,659
Holding current value
$4.42 Million
% of portfolio
10.82%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $3.91 Million - $4.25 Million
69,659 New
69,659 $4.22 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Hgc Investment Management Inc. Portfolio

Follow Hgc Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hgc Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hgc Investment Management Inc. with notifications on news.